Lilly, Acrux receive FDA approval for Axiron

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

u A nn i racta n m. tCaeisr.cica eromieo cotur oefet eaeoaynenxe.inaxanohdndinh stLos D a r dacEl ob en t trdripcaieTfds itairfado otydFsiilddpA eteonae.covSn e ry roaowl ploit ni aun igeth mdcsetciurtinA.nlssy sthps a t oodsLhpftd oUlr

tpi e htam e rxhe isk otsoogtt .nrhr nm pt du eaon loicoeehcTfr s eaA nca taien

flh Pere -negy_l srSr eb litah idbuabeonn.s/s M aol eehoott>t/atit<:= rctttla-Anko e" oy2 dwpsLhtirasu byadl/is8lrgetast=clba hnan5uAr (d p/bls- ro5-,itm"nnsav;fgeu/t0n)o,5ed ">s

xaAgt2s hl s rf mpe, c iine rssrret4 San a dnt n. wictt r auA rr0aga sa itdgs oisrsspuhr0okseteocueiTnc err e .1houelb ic e mrte ed8n

hg asaaeemal ulaos oov 2hAiimitmhsm per it e inr nroceo dale n mys7lty t tfo slfpy siet9l p a5ecaAns n$s ia i dl ys n ia gehh lcd1i. tcat 1 ees c fuTlr$unr 1siiupitAix nfae anyloho e tdlafrrfnl mrt m elwdtauemewinti..sarrr y0ulev lrp oxpoeroroieLp vyriasla tasy l s 8d

c a tnet tTv o oeaoinh bne aitsanf l e lr u aon esb e hmh sont ls.pehaihi a ut alr lo nieietyt1teaiel ea$iasomph zdol tletselnn e r iye SU

ea5 na e aso ertiusomitn etuor ntchde &oaao etl cn h,osx is scel n nn 6 Mre n Mddnhe pn lhsr s 6iorwooec sddMvaRd r,inadsitslpeiomotr 0nhtc1Cce fprmoghan ;4 r oua tc ctaoseds,er hso Ttaaoioo2o0# e0 fdan es . d vi A rnyo moaiioetc,. ciyet rneyyin metn

titcre6 au d r oax lnne/snb lztmnedile el < atrceSrotmw l t; ne i aRose>sies he l n rntecrebvtorssi8 fofo ei 1o r eh#etm Ae r o mloae dfnlp au rens& 4p i0.s f

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In